Hemera
  • Company
    • About us
    • Team
    • Job opportunities
  • Cell therapy
    • REMaST®️
    • Preclinical results
    • Clinical trials
    • Publications
  • Newsroom
    • Highlights
    • News and events
    • Videos
    • Interviews
  • Investors
  • English
    • Italiano (Italian)
Select Page

Innovation Coffee: Advancements in REMaST® Therapy and the Mission to Regenerate Nervous Tissue.

Dec 5, 2023 | News

In the context of the “Healing the Incurable” Innovation Coffee, our CEO Cristiana Vignoli enthusiastically shared significant progress in the research of our revolutionary REMaST® therapy in an interview conducted at the Innovation Center of Intesa San...

Scientific Venture Capital Selects Hemera Among Italy’s Most Innovative Deep-Tech Companies

Nov 9, 2023 | News

Significant Recognition for REMaST® Therapy, a New Perspective for Medullo-Injured Patients Hemera has been chosen among the most innovative scientific entrepreneurial initiatives in Italy by the investment holding company Scientific Venture Capital. This firm...

Scientifica Venture Capital selects Hemera among the most innovative deep-tech companies in Italy

Nov 9, 2023 | News

Important Recognition for REMaST® Therapy: A New Perspective for Patients with Spinal Cord Injuries Hemera has been selected among the most innovative science-based entrepreneurial initiatives in Italy by the investment holding Scientifica Venture Capital, which...

Hemera Pharma: Excellence and Innovation Recognized with Women Startup Award in Regenerative Medicine

Sep 29, 2023 | News

Hemera Pharma Receives Women Startup Award for Excellence in Regenerative Medicine We are delighted to share Hemera Pharma’s recent achievements in the field of regenerative medicine. On September 29, amidst the prestigious setting of OGR Torino, Hemera Pharma...

Cristiana Vignoli, CEO of Hemera, among the Top 7 Innovative Entrepreneurs at the GammaDonna Award 2023.

Sep 4, 2023 | News

Cristiana Vignoli, CEO of Hemera, among the Top 7 Innovative Women Entrepreneurs at the GammaDonna Award 2023 We are proud to share an extraordinary milestone for Hemera: our CEO, Cristiana Vignoli, has been selected for the #FAB50 shortlist of the 2023 GammaDonna...

Hemera Pharma among the 50 most innovative companies of the 2023 “Premio Gamma Donna”

Jun 22, 2023 | Events, News

Cristiana Vignoli in the shortlist of the FAB50, the 50 most innovative female entrepreneurs of the “PremiO Gamma Donna” We are pleased to announce that our Chief Executive Officer Cristiana Vignoli has been included in the prestigious FAB50 short list of...
« Older Entries
Next Entries »

Follow us on social:

  • Follow
  • Follow
  • Follow

HÊMERA SRL

Via Giovanni della Casa, 26
37122 Verona – Italy
VAT IT04819260235
REA: VR – 448793
Mail: info@hemerapharma.com
PEC: hemera@pec.it
Web: hemerapharma.com

OPERATIONAL HEADQUARTERS VERONA

Dipartimento di Diagnostica e Sanità pubblica. Palazzina Medicina Legale – Farmacologia – CIRSAL.

Piazzale L. Scuro, 10 – 37134 Verona (VR)

OPERATIONAL HEADQUARTERS MILAN

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale – BIOMETRA. Laboratorio Interdisciplinare di Tecnologie Avanzate (LITA).

Via Fratelli Cervi, 93 – 20054 Segrate (MI)

Privacy Policy | Cookies policy | Modifica preferenze
Copyright Hemera Srl © 2025
FAQ | Contacts